Metformin use and gynecological cancers: A novel treatment option emerging from drug repositioning

Published 2016 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Metformin use and gynecological cancers: A novel treatment option emerging from drug repositioning
Authors
Keywords
Metformin, Diabetes, Insulin, Insulin-like growth factor [IGF], AMP-activated protein kinase [AMPK], Mammalian target of rapamycin [mTOR], Ovarian cancer, Endometrial cancer, Breast cancer, Chemoprevention
Journal
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
Volume 105, Issue -, Pages 73-83
Publisher
Elsevier BV
Online
2016-06-19
DOI
10.1016/j.critrevonc.2016.06.006

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.